Engineered PAM-SPION Nanoclusters for Enhanced Cancer Therapy: Integrating Magnetic Targeting with pH-Responsive Drug Release
Molecules · 28.06.2025 · 30 (13) · 2785
DOI: 10.3390/molecules30132785 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 28.06.2025. Verfasst von Dimitra Tzavara und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, 26504 Rio Patras, Greece. Hauptthemen laut MEDLINE: Doxorubicin, Magnetite Nanoparticles, Acrylic Resins, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Nanomedicine approaches for cancer therapy face significant challenges, including a poor tumor accumulation, limited therapeutic efficacy, and systemic toxicity. We hypothesized that controlling the clustering of poly(acrylic acid-co-maleic acid) (PAM)-coated superparamagnetic iron oxide nanoparticles (SPIONs) would enhance their magnetic properties for improved targeting, while enabling a pH-responsive drug release in tumor microenvironments.
Methods
PAM-stabilized SPION clusters were synthesized via arrested precipitation, characterized for physicochemical and magnetic properties, and evaluated for doxorubicin loading and pH-dependent release. A dual targeting approach combining antibody conjugation with magnetic guidance was assessed in cellular models, including a novel alternating magnetic field (AMF) pre-treatment protocol.
Results
PAM-SPION clusters demonstrated controlled size distributions (60–100 nm), excellent colloidal stability, and enhanced magnetic properties, particularly for larger crystallites (13 nm). The formulations exhibited a pH-responsive drug release (8.5% at pH 7.4 vs. 14.3% at pH 6.5) and a significant enhancement of AMF-triggered release (17.5%). The dual targeting approach achieved an 8-fold increased cellular uptake compared to non-targeted formulations. Most notably, the novel AMF pre-treatment protocol demonstrated an 87% improved therapeutic efficacy compared to conventional post-treatment applications.
Conclusions
The integration of targeting antibodies, magnetic guidance, and a pH-responsive PAM coating creates a versatile theranostic platform with significantly enhanced drug delivery capabilities. The unexpected synergistic effect of the AMF pre-treatment represents a promising new approach for improving the therapeutic efficacy of nanoparticle-based cancer treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, 26504 Rio Patras, Greece.
- Regional Centre of Advanced Technologies and Materials, Czech Advanced Technology and Research Institute (CATRIN), Palacký University Olomouc, 779 00 Olomouc, Czech Republic.
- Institute of Chemical Engineering Sciences, Foundation for Research and Technology Hellas (FORTH/ICES), 26504 Rio Patras, Greece.
ORCID-Profile: Argiris Kolokithas-Ntoukas, Sophia G Antimisiaris, Athanasios Skouras
Zitieren
APA
Tzavara, D., Papadia, K., Kolokithas-Ntoukas, A., Antimisiaris, S. G., & Skouras, A. (2025). Engineered PAM-SPION Nanoclusters for Enhanced Cancer Therapy: Integrating Magnetic Targeting with pH-Responsive Drug Release. Molecules, 30(13), 2785. https://doi.org/10.3390/molecules30132785
Vancouver
Tzavara D, Papadia K, Kolokithas-Ntoukas A, Antimisiaris SG, Skouras A. Engineered PAM-SPION Nanoclusters for Enhanced Cancer Therapy: Integrating Magnetic Targeting with pH-Responsive Drug Release. Molecules. 2025;30(13):2785. doi:10.3390/molecules30132785
BibTeX
@article{Tzavara2025,
author = {Tzavara, Dimitra and Papadia, Konstantina and Kolokithas-Ntoukas, Argiris and Antimisiaris, Sophia G and Skouras, Athanasios},
title = {Engineered PAM-SPION Nanoclusters for Enhanced Cancer Therapy: Integrating Magnetic Targeting with pH-Responsive Drug Release},
journal = {Molecules},
year = {2025},
volume = {30},
number = {13},
pages = {2785},
doi = {10.3390/molecules30132785}
}
EUVIMED